Anti-asphyxia valve assembly
US-10265496-B2 · Apr 23, 2019 · US
US12594397B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12594397-B2 |
| Application number | US-202017433835-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 26, 2020 |
| Priority date | Feb 26, 2019 |
| Publication date | Apr 7, 2026 |
| Grant date | Apr 7, 2026 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A vent structure may include a vent housing comprising an inlet, an outlet, at least one exhaust gas orifice, and a membrane having a first end and a second end spaced apart, the membrane having a moveable portion between the first end and the second end. The moveable portion may be spaced radially from a membrane-facing surface inside of the vent housing to form an exhaust gas flow passage therebetween to allow exhaust gas to flow from the pressurised volume through the exhaust gas flow passage to atmosphere via the exhaust gas orifice. The moveable portion may be elastically deformable and configured to move radially relative to the membrane-facing surface in response to pressure differences between an interior side of the membrane and an exterior side of the membrane to change a cross-sectional area of the exhaust gas flow passage and regulate the vent flow of gas.
Opening claim text (preview).
The invention claimed is: 1 . A patient interface comprising: a plenum chamber at least partially forming a volume pressurisable to a therapeutic pressure of at least 6 cmH 2 O above ambient air pressure throughout a patient's respiratory cycle in use, and the plenum chamber including a plenum chamber inlet port sized and structured to receive a therapy flow of gas for breathing by a patient, a seal-forming structure constructed and arranged to seal with a region of the patient's face surrounding an entrance to the patient's airways, the seal-forming structure having a hole to deliver the therapy flow of gas to the entrance to the patient's airways during use, and the seal-forming structure being constructed and arranged to maintain the therapeutic pressure in the plenum chamber throughout the patient's respiratory cycle in use; a positioning and stabilising structure comprising a strap configured to hold the seal-forming structure in a therapeutically effective position on the patient's head; a vent structure comprising: a vent housing comprising an inlet configured to be connected to a supply conduit to receive a flow of gas from a respiratory pressure therapy device, an outlet configured to supply the therapy flow of gas to the plenum chamber inlet port, and at least one exhaust gas orifice configured to discharge a vent flow of gas to atmosphere, and the at least one exhaust gas orifice being sized and shaped to discharge a vent flow of gas to atmosphere continuously throughout the patient's respiratory cycle and maintain the therapeutic pressure in the plenum chamber in use; and a membrane positioned within the vent housing and extending circumferentially around a longitudinal axis of the vent housing, the membrane having a first end and a second end spaced apart along a longitudinal axis of the membrane, and the membrane having a moveable portion positioned between the first end of the membrane and the second end of the membrane and surrounding the longitudinal axis of the membrane; wherein the moveable portion of the membrane is spaced radially, with respect to the longitudinal axis of the membrane, from a membrane-facing surface extending circumferentially around an inside of the vent housing to form an exhaust gas flow passage between the moveable portion of the membrane and the membrane-facing surface, and the exhaust gas flow passage being configured to allow gas to flow from the volume at least partially formed by the plenum chamber through the exhaust gas flow passage to atmosphere via the at least one exhaust gas orifice during use, wherein the moveable portion of the membrane is elastically deformable and is configured to move radially relative to the membrane-facing surface in response to differences in pressure throughout a therapeutic pressure range between an interior side of the membrane and an exterior side of the membrane to change a cross-sectional area of the exhaust gas flow passage; and wherein the patient interface is configured to allow the patient to breathe from ambient through their mouth in the absence of a flow of pressurised air through the plenum chamber inlet port, or the patient interface is configured to leave the patient's mouth uncovered. 2 . The patient interface of claim 1 , wherein the moveable portion of the membrane is an annulus that is substantially cylindrical or frustoconical in shape. 3 . The patient interface of claim 1 , wherein the vent housing comprises a first end and a second end aligned along a longitudinal axis of the vent housing, the longitudinal axis of the membrane being aligned with the longitudinal axis of the vent housing. 4 . The patient interface of claim 3 , wherein the moveable portion of the membrane comprises one or more walls aligned parallel to the flow of gas through the vent housing from the first end of the vent housing to the second end of the vent housing. 5 . The patient interface of claim 3 , wherein the vent housing comprises a first housing member at the first end of the vent housing and a second housing member at the second end of the vent housing, and the first housing member and the second housing member being configured to connect together. 6 . The patient interface of claim 5 , wherein the first housing member comprises an inlet connection portion configured to fluidly connect the vent structure to the supply conduit. 7 . The patient interface of claim 5 , wherein the second housing member comprises an outlet connection portion configured to fluidly connect the vent structure to the patient interface or to a tube configured to be connected to the patient interface. 8 . The patient interface of claim 1 , wherein the membrane is joined to a membrane support at the first end of the membrane. 9 . The patient interface of claim 1 , wherein the moveable portion of the membrane is formed from silicone rubber. 10 . The patient interface of claim 1 , wherein the vent structure comprises a damping structure comprising a damping chamber within the vent housing configured to damp vibration of the moveable portion of the membrane. 11 . The patient interface of claim 10 , wherein the vent housing at least partially forms the damping chamber. 12 . The patient interface of claim 10 , wherein one of the interior side and the exterior side of the membrane faces the membrane-facing surface and the other of the interior side and the exterior side of the membrane at least partially forms the damping chamber. 13 . The patient interface of claim 10 , wherein the damping chamber is in fluid communication with the volume at least partially formed by the plenum chamber. 14 . The patient interface of claim 10 , wherein the vent structure is configured such that movement of the moveable portion of the membrane increases or decreases a volume of the damping chamber. 15 . The patient interface of claim 14 , wherein the vent housing and damping chamber are configured to damp vibration of the moveable portion of the membrane by restricting gas exchange between the damping chamber and the volume at least partially formed by the plenum chamber. 16 . The patient interface of claim 1 , wherein the exhaust gas flow passage comprises a restriction region having a smaller cross-sectional area than adjacent regions of the exhaust gas flow passage. 17 . The patient interface of claim 16 , wherein the membrane-facing surface is closest to the moveable portion of the membrane at the restriction region. 18 . The patient interface of claim 16 , wherein the membrane-facing surface comprises a restrictor portion forming the restriction region in the exhaust gas flow passage. 19 . The patient interface of claim 18 , wherein the membrane-facing surface comprises contoured surfaces forming the restrictor portion. 20 . The patient interface of claim 18 , wherein the restrictor portion comprises a rib in the membrane-facing surface. 21 . The patient interface of claim 18 , wherein the restrictor portion is located centrally between the first end of the membrane and the second end of the membrane. 22 . The patient interface of claim 18 , comprising a damping chamber within the vent housing configured to damp vibration of the moveable portion of the membrane, wherein the damping chamber comprises a first end proximal to the first end of the membrane and a second end proximal to the second end of the membrane, and the restriction region in the exhaust gas flow passage being aligned centrally between the firs
Reducing noise · CPC title
Carbon oxides, e.g. Carbon dioxide · CPC title
Holding devices therefor · CPC title
Nasal cannulas or tubing (devices for improving normal breathing through the nose A61F5/08; nose filters A62B23/06; outside holding devices A61M25/02) · CPC title
Non-controlled one-way valves, e.g. exhalation, check, pop-off non-rebreathing valves · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.